Phase II trial of gemcitabine and docetaxel in patients with completely resected stage IIA–IIIA non-small-cell lung cancer

被引：4
|
作者：
Masafumi Kawamura
Keisuke Eguchi
Yotaro Izumi
Yasushi Yamato
Teruaki Koike
Hirozo Sakaguchi
Enjo Hada
Koichi Kobayashi
机构：
[1] Keio University Hospital,Division of General Thoracic Surgery
[2] Niigata Prefectural Cancer Center Hospital,undefined
[3] Mitsui Memorial Hospital,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2007年 / 60卷
关键词：
Non-platinum doublet; Adjuvant chemotherapy; Non-small-cell lung cancer; Docetaxel; Gemcitabin; Surgery;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：495 / 501
页数：6
相关论文
共 50 条
  • [1] Phase II trial of gemcitabine and docetaxel in patients with completely resected stage IIA-IIIA non-small-cell lung cancer
    Kawamura, Masafumi
    Eguchi, Keisuke
    Izumi, Yotaro
    Yamato, Yasushi
    Koike, Teruaki
    Sakaguchi, Hirozo
    Hada, Enjo
    Kobayashi, Koichi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (04) : 495 - 501
  • [2] A phase II study of biweekly gemcitabine and carboplatin in completely resected stage IB-IIIA non-small cell lung cancer
    Sakurai, Reiko
    Tomizawa, Yoshio
    Yoshii, Akihiro
    Miura, Yosuke
    Tsurumaki, Hiroaki
    Kaira, Kyoichi
    Sunaga, Noriaki
    Kawashima, Osamu
    Hisada, Takeshi
    Yamada, Masanobu
    Saito, Ryusei
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (01) : 103 - 109
  • [3] A phase II study of biweekly gemcitabine and carboplatin in completely resected stage IB-IIIA non-small cell lung cancer
    Reiko Sakurai
    Yoshio Tomizawa
    Akihiro Yoshii
    Yosuke Miura
    Hiroaki Tsurumaki
    Kyoichi Kaira
    Noriaki Sunaga
    Osamu Kawashima
    Takeshi Hisada
    Masanobu Yamada
    Ryusei Saito
    Cancer Chemotherapy and Pharmacology, 2018, 81 : 103 - 109
  • [4] Multicenter phase II trial of docetaxel and carboplatin in patients with stage IIIB and IV non-small-cell lung cancer
    Belani, CP
    Einzig, A
    Bonomi, P
    Dobbs, T
    Capozzoli, MJ
    Earhart, R
    Cohen, LJ
    Luketich, JD
    ANNALS OF ONCOLOGY, 2000, 11 (06) : 673 - 678
  • [5] A phase III randomized trial of postoperative adjuvant therapy in Stage II or IIIA completely resected non-small cell lung cancer
    Yoon, S
    Choi, E
    Kim, S
    Suh, C
    Lee, J
    Shim, T
    Kim, W
    Kim, D
    Park, S
    Park, C
    LUNG CANCER, 2005, 49 : S288 - S288
  • [6] A randomized trial comparing adjuvant chemotherapy with gemcitabine plus cisplatin with docetaxel plus cisplatin in patients with completely resected non-small-cell lung cancer with quality of life as the primary objective
    Barlesi, Fabrice
    Chouaid, Christos
    Crequit, Jacky
    Le Caer, Herve
    Pujol, Jean-Louis
    Legodec, Julien
    Vergnenegre, Alain
    Le Treut, Jacques
    Fabre-Guillevin, Elizabeth
    Loundou, Anderson
    Auquier, Pascal
    Simeoni, Marie-Claude
    Thomas, Pascal A.
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2015, 20 (06) : 783 - 790
  • [7] Phase II trial of gemcitabine in advanced non-small-cell lung cancer
    Malayeri, R
    Ulsperger, E
    Baumgartner, G
    Forstner, B
    Aigner, K
    Hubner, M
    Kummer, F
    Krajnik, G
    Zochbauer, S
    Krejcy, K
    Huber, H
    Pirker, R
    WIENER KLINISCHE WOCHENSCHRIFT, 1997, 109 (17) : 688 - 691
  • [8] A randomised phase II trial of two sequential schedules of docetaxel and cisplatin followed by gemcitabine in patients with advanced non-small-cell lung cancer
    Francesco Grossi
    Filippo de Marinis
    Vittorio Gebbia
    Ferdinando Riccardi
    Orazio Caffo
    Teresa Gamucci
    Francesco Ferraù
    Mario Nardi
    Luca Moscetti
    Luca Boni
    Davide Dondi
    Enzo Galligioni
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 369 - 375
  • [9] A randomised phase II trial of two sequential schedules of docetaxel and cisplatin followed by gemcitabine in patients with advanced non-small-cell lung cancer
    Grossi, Francesco
    de Marinis, Filippo
    Gebbia, Vittorio
    Riccardi, Ferdinando
    Caffo, Orazio
    Gamucci, Teresa
    Ferrau, Francesco
    Nardi, Mario
    Moscetti, Luca
    Boni, Luca
    Dondi, Davide
    Galligioni, Enzo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (02) : 369 - 375
  • [10] Class III β-Tubulin Expression in Tumor Cells is Correlated with Resistance to Docetaxel in Patients with Completely Resected Non-Small-Cell Lung Cancer
    Hayashi, Yoshiki
    Kuriyama, Hideyuki
    Umezu, Hajime
    Tanaka, Junta
    Yoshimasu, Tatsuya
    Furukawa, Tomoko
    Tanaka, Hiroshi
    Kagamu, Hiroshi
    Gejyo, Fumitake
    Yoshizawa, Hirohisa
    INTERNAL MEDICINE, 2009, 48 (04) : 203 - 208
12345